Hana Pharm Co., Ltd. (293480.KS)
KRW 10850.0
(-0.73%)
KRW 10850.0
(-0.73%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 48.34 Billion KRW | 16.77% |
| 2022 | 41.4 Billion KRW | 1.75% |
| 2021 | 40.69 Billion KRW | 32.42% |
| 2020 | 30.72 Billion KRW | 14.3% |
| 2019 | 26.88 Billion KRW | 22.18% |
| 2018 | 22 Billion KRW | 14.2% |
| 2017 | 19.26 Billion KRW | 6.9% |
| 2016 | 18.02 Billion KRW | 25.31% |
| 2015 | 14.38 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 50.38 Billion KRW | 4.23% |
| 2024 Q1 | 48.33 Billion KRW | -0.02% |
| 2023 Q2 | 48.01 Billion KRW | 7.35% |
| 2023 Q1 | 44.72 Billion KRW | 8.03% |
| 2023 FY | 48.34 Billion KRW | 16.77% |
| 2023 Q4 | 48.34 Billion KRW | -1.85% |
| 2023 Q3 | 49.25 Billion KRW | 2.59% |
| 2022 Q1 | 40.27 Billion KRW | -1.03% |
| 2022 FY | 41.4 Billion KRW | 1.75% |
| 2022 Q4 | 41.4 Billion KRW | 6.21% |
| 2022 Q3 | 38.98 Billion KRW | -3.51% |
| 2022 Q2 | 40.4 Billion KRW | 0.32% |
| 2021 Q3 | 40 Billion KRW | 9.52% |
| 2021 Q4 | 40.69 Billion KRW | 1.72% |
| 2021 FY | 40.69 Billion KRW | 32.42% |
| 2021 Q1 | 35.02 Billion KRW | 13.99% |
| 2021 Q2 | 36.52 Billion KRW | 4.28% |
| 2020 Q3 | 30.31 Billion KRW | 1.74% |
| 2020 Q4 | 30.72 Billion KRW | 1.37% |
| 2020 FY | 30.72 Billion KRW | 14.3% |
| 2020 Q1 | 28.88 Billion KRW | 7.43% |
| 2020 Q2 | 29.79 Billion KRW | 3.16% |
| 2019 Q4 | 26.88 Billion KRW | 5.98% |
| 2019 FY | 26.88 Billion KRW | 22.18% |
| 2019 Q3 | 25.36 Billion KRW | 7.6% |
| 2019 Q1 | 23.87 Billion KRW | 8.48% |
| 2019 Q2 | 23.57 Billion KRW | -1.23% |
| 2018 FY | 22 Billion KRW | 14.2% |
| 2018 Q3 | 20.86 Billion KRW | 7.34% |
| 2018 Q4 | 22 Billion KRW | 5.46% |
| 2018 Q2 | 19.44 Billion KRW | 0.0% |
| 2017 FY | 19.26 Billion KRW | 6.9% |
| 2016 FY | 18.02 Billion KRW | 25.31% |
| 2015 FY | 14.38 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -9.502% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | 58.976% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | 46.968% |
| HANDOK Inc. | 94.46 Billion KRW | 48.82% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -127.591% |
| Yuhan Corporation | 284.75 Billion KRW | 83.022% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | 58.434% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -197.363% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 83.26% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -49.293% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | 21.673% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -148.227% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -59.666% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -9.502% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -54.757% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -37.442% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -0.455% |
| JW Holdings Corporation | 147.58 Billion KRW | 67.242% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | 42.868% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 81.507% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 54.429% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | 10.341% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -79.078% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -48.709% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | 55.955% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -9.502% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | 74.371% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 79.984% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 54.429% |
| Yuhan Corporation | 284.75 Billion KRW | 83.022% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | 61.409% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | 22.004% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 81.394% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 54.429% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | 39.264% |
| Korea United Pharm Inc. | 49.14 Billion KRW | 1.617% |
| CKD Bio Corp. | 69.08 Billion KRW | 30.015% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | 53.989% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | 31.614% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | 10.564% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | 10.341% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | 75.177% |
| Boryung Corporation | 189.8 Billion KRW | 74.528% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | 14.929% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | 21.673% |
| JW Lifescience Corporation | 23.39 Billion KRW | -106.625% |